Eubiotics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Probiotics, Prebiotics, Organic Acids and Essential Oils), By Livestock (Poultry, Swine, Ruminants, Aquatic Animals and Others), By Function (Nutrition and Gut Health, Yield, Immunity & Production), By Form (Dry and Liquid), By Region and Competition, 2020-2030F

Market Overview

The Global Eubiotics Market, valued at USD 7.94 Billion in 2024, is projected to experience a CAGR of 7.91% to reach USD 12.54 Billion by 2030. Eubiotics, a category of feed additives encompassing probiotics, prebiotics, organic acids, and essential oils, are designed to establish and maintain a balanced microflora within the gastrointestinal tract of animals, a state known as eubiosis, thereby enhancing animal health and performance. The market's expansion is primarily driven by increasing consumer demand for natural feed additives, growing awareness regarding livestock health and productivity, and evolving regulatory restrictions on the use of antibiotic growth promoters in animal feed. These factors collectively stimulate the adoption of eubiotic solutions across various livestock sectors.

According to the International Feed Industry Federation (IFIF) citing Alltech's 2024 Agri-Food Outlook, in 2023, total global compound feed production was approximately 1.29 billion metric tons, reflecting the extensive application context for eubiotics. However, a significant challenge impeding market growth is the high production cost associated with advanced eubiotic formulations and the complex, stringent regulatory frameworks that necessitate substantial investment in research, development, and compliance for new product approvals.

Key Market Drivers

The growth of the Global Eubiotics Market is significantly influenced by stringent regulations on antibiotic growth promoters. Global legislative shifts aim to mitigate antimicrobial resistance, compelling livestock producers to seek alternative solutions for animal health and productivity. This regulatory pressure directly fuels the demand for eubiotics, which serve as effective substitutes for traditional antibiotics in maintaining gut health. For instance, according to the European Medicines Agency's European Surveillance of Veterinary Antimicrobial Consumption thirteenth annual report, published in November 2023, overall sales of veterinary antibiotics in 25 European countries decreased by 53% between 2011 and 2022. This substantial reduction mandates the adoption of non-antibiotic feed additives, driving innovation and market expansion for eubiotic products.

Alongside regulatory mandates, increasing consumer preference for antibiotic-free animal products is a pivotal driver. Growing public awareness regarding the potential health risks associated with antibiotic residues in meat and the broader issue of antimicrobial resistance has led to a pronounced shift in purchasing habits. Consumers are actively seeking animal proteins produced without antibiotics, thereby pressuring the supply chain to adopt eubiotic solutions. For example, according to a European Environment Agency (EEA) report published in May 2024, 'Sustainable use of veterinary antimicrobials in Europe: EEA report', antimicrobial-resistant infections cause an estimated 35,000 deaths annually in the European Economic Area, highlighting the public health concern that underpins this consumer demand. This demand directly encourages livestock and aquaculture producers to integrate eubiotics to meet market expectations. The broader animal nutrition sector reflects this dynamic, with significant activity in related segments; for instance, dsm-firmenich announced in February 2025 that the activities in its Feed Enzymes Alliance, a component of advanced feed solutions, represented approximately €300 million in total annual net sales in 2024.

Download Free Sample Report

Key Market Challenges

A significant challenge impeding the growth of the Global Eubiotics Market is the combination of high production costs associated with advanced formulations and the complex, stringent regulatory frameworks governing their approval. These elevated production costs directly contribute to higher selling prices for eubiotic products, which can render them less competitive compared to more traditional or conventional feed additives. This pricing disparity often limits affordability and widespread adoption among livestock producers, particularly smaller operations operating with narrower profit margins.

Furthermore, the rigorous regulatory landscape significantly exacerbates these cost pressures. Bringing novel eubiotic formulations to market necessitates substantial investment in research, development, and extensive compliance testing to meet stringent safety and efficacy standards. According to Eurostat, gross domestic expenditure on research and development across the European Union stood at €389 billion in 2023, reflecting the immense financial commitment required for innovation in regulated sectors. The animal feed additive industry, including eubiotics, contributes to this substantial R&D landscape, as the need to demonstrate scientific evidence and ensure regulatory adherence adds considerable overhead, extending development timelines and inflating the financial barrier to market entry for new and improved products.

Key Market Trends

The Global Eubiotics Market is significantly influenced by Advancements in Eubiotic Formulation and Delivery Technologies. This trend involves the development of novel eubiotic structures, enhanced stability, and targeted release mechanisms that improve efficacy within the animal gastrointestinal tract. Such advancements allow for more effective and consistent delivery of beneficial microorganisms and compounds, optimizing nutrient absorption and overall animal health. For instance, in 2023, Novozymes entered a joint development and commercialization agreement with Danish biotech company Bactolife to finalize and launch Ablacto+, a biosolution aimed at stabilizing piglets' gut health and reducing the severity of post-weaning diarrhea. These innovations are crucial as the industry seeks to replace traditional antibiotic growth promoters.

Another pivotal trend is the Development of Personalized Eubiotic Solutions. This involves tailoring eubiotic products to the specific needs of different animal species, age groups, or physiological states, often informed by detailed animal health data and microbial analysis. This precision approach maximizes the benefits of eubiotics by providing targeted support for specific challenges, thereby improving feed efficiency and performance more effectively. According to Alltech's 2025 Agri-Food Outlook, global feed production saw a positive turn in 2024, with an increase of 1.2%, reaching 1.396 billion tonnes, highlighting the vast application landscape for such tailored solutions. An example of this customization includes Phileo by Lesaffre, an animal nutrition company, which in January 2023, launched Actisaf Sc 47 HR+ probiotics specifically for the poultry sector to help improve feed efficiency and production performance in birds. This specialization drives market growth by offering higher value and more impactful products to livestock producers.

Segmental Insights

Within the Global Eubiotics Market, the Probiotics segment stands out as the fastest-growing due to several convergent factors. There is an increasing recognition of the significance of gut health in both animal and human populations, driving demand for beneficial feed additives. Concurrently, stringent global regulations, such as those implemented by the European Union classifying probiotics as gut flora stabilizers under feed additive regulations, restrict the use of antibiotic growth promoters in livestock, thereby accelerating the adoption of natural alternatives. This shift is further fueled by growing consumer preference for antibiotic-free meat and dairy products, encouraging producers to integrate probiotics for enhanced animal performance and food safety.

Regional Insights

Asia Pacific holds a leading position in the global eubiotics market, primarily driven by its substantial and expanding animal husbandry and aquaculture sectors. The significant populations and rising disposable incomes in countries like China and India fuel a substantial demand for animal protein, including meat and seafood. This robust consumption necessitates advanced animal nutrition and health solutions. Furthermore, increasing regulatory emphasis on limiting antibiotic growth promoters, advocated by bodies such as the World Organisation for Animal Health (WOAH), promotes the wider adoption of eubiotics as sustainable alternatives.

Recent Developments

• In June 2025, dsm-firmenich Animal Nutrition & Health introduced GutServ® Biotix, a novel postbiotic solution designed to bolster piglet health, resilience, and overall performance. This innovation is particularly aimed at supporting piglets during critical stress periods, such as weaning. The company emphasized that by strengthening gut integrity and functionality, GutServ® Biotix helps minimize early-life setbacks, enabling piglets to achieve efficient growth and establish a robust foundation for sustained development. Scientific validation through multiple international trials demonstrated a positive return on investment, and the solution is compatible with all feed types and processing conditions, ensuring flexible integration into existing farm operations.

• In June 2025, ADM launched two new compound probiotic combinations, named Balance and Restore, at the 15th China International Health Products Exhibition. These additions were designed to broaden the company’s scientific nutrition product portfolio within the Global Eubiotics Market. The Balance probiotic combination specifically supports intestinal health, metabolic functions, liver health, and lactation health. Concurrently, the Restore probiotic is a multi-strain formula developed for children’s health, aiming to support intestinal, immune, and digestive well-being, while also helping to relieve gastrointestinal discomfort and promote microecological balance. ADM focused on showcasing its clinically supported strains and innovative delivery platforms across various health segments.

• In March 2025, IFF expanded its Enviva® PRO probiotic range to include specific applications for swine. New studies revealed that this three-strain Bacillus probiotic can offer enhanced protection to weaned piglets against various health challenges. Integrating IFF’s probiotic into pig diets is intended to better position producers to improve animal welfare and performance. The company highlighted that the stable formulation of Enviva® PRO ensures uniform and consistent delivery through water distribution systems, preventing sedimentation and maintaining operational efficiency. This extended probiotic solution became available to poultry integrators and large farm complexes in the U.S., India, and Pakistan, with plans for further global expansion subject to regulatory approvals.

• In January 2025, Novus International, Inc., an intelligent nutrition company, established a strategic co-development partnership with Resilient Biotics. This collaboration aims to create a novel feed solution focused on enhancing immune health and mitigating the risk of respiratory challenges in pigs. The partnership will utilize Resilient Biotics’ proprietary microbiome product discovery platform and extensive collection of swine microbials to develop precision eubiotic solutions. Both companies are committed to developing a product that offers consistent, measurable benefits to the swine industry, which frequently faces significant economic losses from respiratory issues. This initiative aligns with Novus’s vision of providing science-backed technologies for sustainable animal agriculture.

Key Market Players

• Novozymes A/S
• Cargill, Incorporated
• DuPont de Nemours, Inc.
• Koninklijke DSM N. V.
• Lallemand Inc.
• Novus International, Inc.
• Kemin Industries, Inc.
• Asahi Group Holdings, Ltd.

Report Scope:

In this report, the Global Eubiotics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Eubiotics Market, By Type:

o   Probiotics

o   Prebiotics

o   Organic Acids

o   Essential Oils

• Eubiotics Market, By Livestock:

o   Poultry

o   Swine

o   Ruminants

o   Aquatic Animals

o   Others

• Eubiotics Market, By Function:

o   Nutrition & Gut Health

o   Yield

o   Immunity & Production

• Eubiotics Market, By Form:

o   Dry

o   Liquid

• Eubiotics Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Eubiotics Market.

Available Customizations:

Global Eubiotics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Eubiotics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]